BRK-B vs CME
By Alex · Tickerpine
Berkshire Hathaway Inc. vs CME Group Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | BRK-B | CME |
|---|---|---|
| Price | $498.66 | $221.00 |
| Market cap | $1.08T | $79.85B |
| P/E ratio | 14.8 | 18.9 |
| ROE | 10.50% | 15.92% |
| Profit margin | 19.30% | 63.32% |
| Revenue growth | 4.40% | 14.40% |
| Dividend yield | — | 2.35% |
| Beta | 0.62 | 0.24 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
BRK-B vs CME in plain English
- BRK-B is the bigger company — about 13.5× the market cap of CME.
- BRK-B is cheaper on earnings (P/E 14.8 vs 18.9).
- CME earns a higher return on equity (16% vs 10%).
- CME is growing revenue faster (14% vs 4%).
- CME pays a dividend (2.35%) while the other effectively doesn't.
How would $1,000 have done in each?
BRK-B return calculator
See what $1,000 in Berkshire Hathaway Inc. would be worth today.
CME return calculator
See what $1,000 in CME Group Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.